euglena Co rolls out its own brand product in Singapore:
Launch of “Euglena P-3”, a dietary supplement containing Euglena gracilis

euglena Co., Ltd.

　euglena Co., Ltd. (“euglena Co”, headquartered in Minato-ku, Tokyo ; Mitsuru Izumo, President) announces the launch of a dietary supplement containing Euglena gracilis “Euglena P-3,” the first own brand product dedicated to overseas marketing, in Singapore from April 25, 2017.

　Together with the recent economic growth in the Asian countries, the health food market in the region has also shown the trend of expansion. euglena Co has already initiated the overseas marketing of dietary supplements containing Euglena gracilis in China through its joint venture company, Shanghai euglena Biotechnology Co., Ltd. As a new step for further business expansion overseas, euglena Co launches “Euglena P-3” in Singapore. “Euglena P-3” is its first own brand product dedicated to overseas marketing. “Euglena P-3” contains nutritionally well-balanced Euglena gracilis blended with Bifidobacterium and Fructooligosaccharides to support the health of people leading a busy life.
　We launch this product in Singapore with a view for future expansions in South-East Asian countries to create an overseas market for Euglena gracilis following China.
　The detailed description of the product is followed.

“Euglena P-3”

≻ Characteristics: Bifidobacterium and Fructooligosaccharides are mixed with nutrient-rich Euglena gracilis to support balanced diet for day-to-day
　health and beauty.
≻ Serving size: 3 vegetarian capsules per day
≻ Servings per container: 30 servings (90 vegetarian capsules)
≻ Ingredients: Euglena gracilis, Bifidobacterium breve B-3™, hydroxypropyl methylcellulose, corn starch, fructooligosaccharides, calcium stearate,
　silicon dioxide, carthamus yellow, gardenia blue
≻ Price: 120 Sigapore Dollar (tax included)
≻ Release Date: April 25, 2017
≻ Available at: EC site, Clinics, Pharmacies in Singapore
≻ URL: http://www.euglena.jp/sg/p-3/

< About Euglena gracilis >
　Euglena gracilis is a species of microalgae containing well-balanced nutrients, including vitamins and minerals. It exhibits both plant and animal characteristics. Its own unique component “paramylon”, which is a kind of dietary fiber composed ofβ-1, 3-glucan, has varieties of functionality.

< About euglena Co.,Ltd. >
　euglena Co.,Ltd., listed on the first section of Tokyo Stock Exchange (Ticker: 2931), is the first biotechnology venture company in the world that succeeded in outdoor mass cultivation of microalgae “Euglena” in 2005. We currently operate a Healthcare Business for marketing “Euglena” functional foods/cosmetics and an Energy & Environment Business promoting R&D for biofuel production. The financial results for the fiscal year ending September 2016 were JPY11.1 billion sales, JPY944 million ordinary income and JPY673 million net income.

– Contact information –
euglena Co.,Ltd.,
Corporate Strategy department, Corporate Communications Section